Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | 2025-07-09 | 32,979 | $15.69 | $517.54kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-07-09 | 30,250 | $15.69 | $474.71kSell |
Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | 2025-06-09 | 7,169 | $14.50 | $103.95kSell |
Paul K. Audhya | CHIEF MEDICAL OFFICER | 2025-05-23 | 2,146 | $11.31 | $24.27kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-05-23 | 1,926 | $11.31 | $21.78kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-05-22 | 2,317 | $11.88 | $27.52kSell |
Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | 2025-05-22 | 9,999 | $11.88 | $118.75kSell |
Paul K. Audhya | CHIEF MEDICAL OFFICER | 2025-05-22 | 2,689 | $11.88 | $31.93kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-05-19 | 2,600 | $11.84 | $30.79kSell |
Paul K. Audhya | CHIEF MEDICAL OFFICER | 2025-05-19 | 2,776 | $11.84 | $32.88kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Vivo Ventures VI LLC | 16.83% | 8,409,126 | $132.78M | Insider |
Vr Adviser LLC | 13.42% | 6,703,985 | $105.86M | Institution |
Venrock Healthcare Capital Partners III LP | 10.62% | 5,303,985 | $83.75M | Insider |
Tang Capital Management LLC | 9.89% | 4,941,798 | $78.03M | Institution |
Suvretta Capital Management LLC | 9.84% | 4,913,012 | $77.58M | Institution |
Frazier Life Sciences Management LP | 9.78% | 4,887,867 | $77.18M | Institution |
Vestal Point Capital LP | 9.51% | 4,751,292 | $75.02M | Institution |
Interwest Management Partners IX LLC | 9.25% | 4,619,196 | $72.94M | Insider |
Acmp IV LLC | 8.70% | 4,343,550 | $68.58M | Insider |
Guy P. Nohra | 8.70% | 4,343,550 | $68.58M | Insider |